Remember that non-fatal stroke is the most expensive diagnosis we have in medicine, along with alcoholism.
与酗酒相似，非致死性卒中是目前诊断所需花费最高的疾病。
One disabling or fatal stroke would be prevented for every approximately 200 patients treated for 1 year with clopidogrel added to aspirin.
对200名病人进行为期一年的氯吡格雷加阿司匹林联合治疗大约可以预防一起致残或致死性卒中的发生。
The main outcome measures were atherosclerotic events, including fatal or nonfatal ischemic heart disease, fatal or nonfatal stroke, and peripheral arterial disease.
主要的衡量结果为动脉粥样硬化性事件，包括致命的或非致命性缺血性心脏病，致命性的或非致命性中风及外周动脉疾病。
Before administering treatment to stroke patients, a doctor must figure out what type of stroke that person has had, because using the wrong drug can be fatal.
在对中风病人进行治疗前，医师必须了解病人所患的中风类型，否则，错误用药可能致命。
Then Cavic made a fatal mistake, gliding toward the finish, while Phelps snuck in an extra half-stroke.
但是紧接着科瓦奇犯了致命错误，他滑向了终点。而菲尔普斯则拼尽全力发动了最后一击。
In Britain, 150, 000 people suffer a stroke each year, with around 67, 000 being fatal.
在英国，每年有15万人罹患中风，其中约有六万七千人因此而死亡。
The report notes that obesity can lead to potentially fatal health problems including diabetes, stroke and cancer.
报道指出，肥胖导致的健康问题有可能是致命的，如糖尿病、中风以及癌症。
Main Outcome Measures The primary end point was a composite of initial fatal or nonfatal coronary event or stroke or revascularization.
复合终点为初次致命或非致命性冠状动脉事件、卒中和血管重建。
Over an average of 8.2 years of follow-up, 554 participants experienced fatal and nonfatal cardiovascular events, including myocardial infarction, stroke, coronary artery disease, and heart failure.
平均随访8.2年，共有554名参与者出现致死性和非致死性心血管事件，包括心肌梗死、卒中、冠心病和心力衰竭。
The report notes that obesity can lead to potentially fatal health problems including diabetes, stroke and cancer. But unfortunately, the obesity epidemic in America is getting worse.
报道指出，肥胖导致的健康问题有可能是致命的，如糖尿病、中风以及癌症。然而不幸的是，在美国，肥胖症正愈演愈烈。
Overall differences between iron reduction and control groups for all cause mortality or death plus non-fatal myocardial infarction (MI) and stroke were not statistically significant.
铁降低组与对照组在全病死亡率或死亡加非致死性心肌梗塞（MI）和中风方面的整体差异均不具有统计学显著性。
Overall differences between iron reduction and control groups for all cause mortality or death plus non-fatal myocardial infarction (MI) and stroke were not statistically significant.
铁降低组与对照组在全病死亡率或死亡加非致死性心肌梗塞（MI）和中风方面的整体差异均不具有统计学显著性。
应用推荐